Investigating the impact of COVID-19 on mortality across different birth cohorts and races
COVID-19 and Cohort Longevity: Causal Estimates from a Cohort Discontinuity Design
This study looks at how COVID-19 has changed death rates for different groups of people in France and the U.S., especially comparing men and women and different races, to better understand the pandemic's impact on survival rates.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11091645 on NIH RePORTER |
What this research studies
This research examines how COVID-19 has affected the mortality rates of specific birth cohorts in both France and the United States, focusing on differences between males and females as well as racial disparities among Americans. By utilizing a novel cohort discontinuity design, the study aims to provide causal estimates of the pandemic's impact on all-cause mortality. The research will analyze secondary data from vital registers to ensure high-quality and detailed insights into mortality trends. This approach will help clarify how the pandemic has influenced survival rates and whether it has reversed progress made prior to the pandemic.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from specific birth cohorts in the U.S. and France, particularly those who identify as Black or White.
Not a fit: Patients who do not belong to the specified birth cohorts or racial groups may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could provide critical insights into the long-term effects of COVID-19 on mortality, informing public health strategies and interventions.
How similar studies have performed: Previous research has successfully utilized cohort analysis to study mortality trends, making this approach both relevant and promising.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Guillot, Michel — University of Pennsylvania
- Study coordinator: Guillot, Michel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.